CRISIL Assigns 'Crisil ESG 59' Score to Shilpa Medicare
Shilpa Medicare Ltd 路 Others (Uncategorized) 路 23 Sept 2026, 8:38 pm
CRISIL Assigns 'Crisil ESG 59' Score to Shilpa Medicare CRISIL ESG Ratings & Analytics has assigned Shilpa Medicare an ESG score of "Crisil ESG 59". The rating was derived from the company's FY26 disclosures and publicly available data. Shilpa Medicare confirmed it did not formally engage the agency for this assessment; the score was independently evaluated by CRISIL using public domain information, pursuant to SEBI Regulation 30 disclosure norms.
Original exchange filing (PDF)
More announcements from Shilpa Medicare Ltd
- Q2FY27 Earnings Conference Call 05 November 2026 路 11 Nov 2026
- Audio link of the Investor Conference call for the quarter ended 30 September 2026. 路 06 Nov 2026
- Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited 路 05 Nov 2026
- Investor Presentation for the Quarter and Half year ended 30 September 2026 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Financial Results for the Quarter and Half year ended 30 September 2026 路 05 Nov 2026
- SHILPA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
